Chapter 6 — Introduction to Biotechnology

Definition and core idea
Biotechnology is the application of biological knowledge, organisms and cellular processes to develop products and technologies that benefit humans, animals and the environment. At its heart, biotechnology takes advantage of natural mechanisms — such as microbial metabolism or genetic inheritance — and applies tools to control and harness these processes for useful outcomes.

Interdisciplinary nature
Biotechnology sits at the intersection of biology, chemistry, genetics, microbiology and engineering. It uses chemistry to purify molecules, genetics to alter sequences, microbiology to culture organisms and engineering to scale processes into industrial production. This combination means that a biotechnologist must understand living systems at different levels, from molecules to whole organisms, and be able to design experiments and practical systems to meet objectives.

Everyday examples
Many everyday products come from simple biotechnological ideas. Bread and yogurt are ancient forms of biotechnology: they use yeast and bacteria respectively to change raw ingredients into food. Modern biotechnology builds on similar biological principles but with controlled laboratory methods to create medicines, vaccines, diagnostic kits, improved crops and biofuels. For instance, producing human insulin in bacteria replaces older methods that used animal pancreas, improving safety and supply.

Types of biotechnology
Biotechnology is often grouped by application: medical (therapeutics, diagnostics), agricultural (GM crops, plant tissue culture), industrial (enzymes, biofuels, biodegradable plastics), and environmental (bioremediation, waste treatment). Beyond these, newer areas such as synthetic biology design entirely new biological systems for specific purposes, while bioinformatics applies computational tools to manage biological data.

Benefits and trade-offs
Biotechnology offers benefits like improved health care, higher crop yields and more sustainable manufacturing. However, it also raises questions about safety, ecological impact and fair access. Responsible use requires regulation, biosafety measures and ethical reflection. Learning biotechnology therefore combines practical lab skills, conceptual understanding and awareness of social consequences.

How the unit approaches the topic
This unit introduces essential biological bases — cells, biomolecules and genetics — before moving to tools such as restriction enzymes, plasmids, cloning and PCR. Emphasis is on understanding how techniques work and why they matter, illustrated by applications like insulin production, diagnostics and GM crops. Students will be encouraged to draw diagrams, follow simple protocols safely, and connect molecular events to real-world outcomes.

Ancient and traditional roots
Biotechnology in practice is older than modern science. For thousands of years people have used living systems to make food and drink: fermentation by yeast produces bread and alcoholic beverages, and bacterial fermentation produces yoghurt and cheese. Selective breeding of plants and animals is another early form of biotechnology, where desirable traits were chosen over generations to improve crops and livestock.

Foundations in genetics and microbiology
The scientific basis of modern biotechnology developed after key discoveries in the 19th and 20th centuries. Gregor Mendel’s work on inheritance established the idea of discrete hereditary units. The discovery that DNA is the molecule of heredity and subsequent work on the structure of DNA revealed how genetic information is stored. Microbiology developed methods to culture and study microorganisms, making it possible to manipulate them in the laboratory.

The recombinant DNA revolution
Major leaps occurred when restriction enzymes and DNA ligases were discovered and characterised. These enzymes allow DNA to be cut and joined in specific ways, enabling scientists to assemble recombinant DNA molecules. The development of plasmid vectors to carry foreign DNA into bacteria and the demonstration that bacteria can express foreign genes made industrial production of human proteins possible — a landmark being the production of human insulin in bacteria in the late 1970s and early 1980s.

Techniques that expanded capabilities
The invention of the polymerase chain reaction (PCR) in the 1980s allowed rapid amplification of specific DNA sequences, revolutionising diagnostics and research. Improvements in DNA sequencing technology, from Sanger sequencing to next-generation methods, made genome analysis affordable and routine. These advances led to the Human Genome Project and an era of genomics that underpins personalized medicine and modern bioinformatics.

Modern developments and synthetic biology
More recent milestones include development of monoclonal antibody technologies, recombinant vaccines, and gene therapy vectors. The arrival of genome editing tools — especially CRISPR-based systems — provided precise, efficient ways to change DNA sequences in cells, widening possibilities for therapy and agriculture. Synthetic biology seeks to design and build biological parts, devices and systems from standard components, bringing engineering approaches into biology.

Social and regulatory milestones
Alongside technical advances, society developed norms and regulations to manage risks. Ethical debates and regulatory frameworks evolved in response to new capabilities, balancing innovation with public safety and environmental protection. Understanding the history shows how scientific discoveries, technical tools and social responses together shape the practice of biotechnology today.

Wide-ranging impact
Biotechnology affects many areas of daily life and industry. Its scope ranges from small diagnostic kits used in clinics to large-scale industrial fermentation plants producing enzymes or biofuels. Understanding the scope helps students see how molecular and cellular techniques are translated into products and services that address health, agriculture, environment and economy.

Medical and healthcare applications
Medical biotechnology produces therapeutics such as insulin, growth hormones and monoclonal antibodies; develops vaccines and creates diagnostic tests based on DNA, RNA or proteins. Molecular diagnostics use PCR and sequencing to detect pathogens or genetic markers, enabling faster and more accurate disease identification and monitoring. Biotech is also vital in regenerative medicine and gene therapy research.

Agricultural biotechnology
In agriculture, biotechnology improves crop yield, quality and resistance to stresses. Techniques include genetic modification to introduce traits such as insect resistance or herbicide tolerance, marker-assisted selection to speed breeding, and tissue culture for rapid propagation of elite varieties and production of disease-free planting material. Biotechnology also supports livestock through vaccines, diagnostics and improved breeding strategies.

Industrial biotechnology
Industrial or white biotechnology uses microbes and enzymes to produce chemicals, food ingredients, detergents, textiles and biofuels. Enzymes can catalyse reactions under mild conditions reducing energy use and pollution. Microbial fermentation converts renewable biomass into ethanol, organic acids and other platform chemicals, supporting more sustainable manufacturing.

Environmental biotechnology
Biotechnology helps clean up pollutants through bioremediation, where microorganisms degrade toxic compounds in soil, water or waste streams. Wastewater treatment uses microbial consortia to remove organic matter and nutrients. These approaches can restore ecosystems and reduce environmental impact compared to chemical treatments.

Research, diagnostics and emerging areas
Laboratory biotechnology tools underpin basic research in genetics, cell biology and ecology. Bioinformatics analyses large biological data sets, while synthetic biology aims to design novel biological systems for specific functions such as biosensors or microbial factories. Personalized medicine uses genomic information to tailor treatments to individuals.

Socioeconomic aspects
Biotechnology drives economic growth by creating new products, companies and jobs. It raises policy issues about access, intellectual property, biosafety and ethics. Educating students about applications and implications prepares them to participate thoughtfully in debates and careers related to biotechnology.

Cells as the basic unit of life
All living organisms are made of cells; understanding cell structure is essential in biotechnology because many techniques act at the cellular level. Cells provide the environment where genetic information is stored, read and executed to produce proteins and other molecules. Different cell types have specialised structures (organelles) where specific biochemical processes occur.

Prokaryotic versus eukaryotic cells
Prokaryotic cells (for example, bacteria) are simple in organization: they lack a membrane-bound nucleus and most organelles, and their DNA is found in a nucleoid region. Eukaryotic cells (plants, animals, fungi and protists) have a true nucleus and membrane-bound organelles such as mitochondria and endoplasmic reticulum. Biotechnologists choose hosts (bacteria, yeast, mammalian cells) based on the capabilities required for expression and processing of proteins.

Key organelles and their functions
The nucleus houses DNA and coordinates replication and transcription. Mitochondria are sites of cellular respiration and ATP production. In plant cells, chloroplasts carry out photosynthesis. The endoplasmic reticulum (ER) synthesises proteins and lipids; rough ER has ribosomes attached for protein synthesis, while smooth ER is involved in lipid synthesis and detoxification. The Golgi apparatus modifies, sorts and packages proteins for secretion or delivery to other organelles. Lysosomes contain hydrolytic enzymes for digestion and recycling of cellular components. Ribosomes, present in prokaryotes and eukaryotes, are the molecular machines that translate mRNA to protein.

Cell membrane and transport processes
The cell membrane is a phospholipid bilayer with embedded proteins that control movement of ions and molecules. Passive diffusion, facilitated transport and active transport across membranes determine nutrient uptake and waste removal. Endocytosis and exocytosis in eukaryotes mediate uptake and secretion of larger molecules. Membrane properties are central to processes such as transformation, where DNA must cross membranes, and to drug delivery strategies.

Special structures in prokaryotes
Bacteria may possess additional features like plasmids (extra-chromosomal DNA), pili for attachment or conjugation, and flagella for motility. Plasmids are widely used as vectors in biotechnology because they can carry foreign genes and replicate independently.

Why structure matters in biotechnology
Different organelles create environments that influence protein folding, post-translational modification and stability. For instance, eukaryotic proteins requiring glycosylation may not be correctly processed in bacteria; such proteins are better produced in yeast, insect or mammalian cell cultures. Understanding cellular compartments helps design experiments for expression, secretion and purification of recombinant products.

Four major classes of biomolecules
All living systems rely on four principal classes of biomolecules: carbohydrates, proteins, lipids and nucleic acids. Each class has distinctive chemical features and biological roles. Biotechnology manipulates these molecules directly (for example, producing a recombinant protein) or indirectly (for instance, engineering metabolic pathways to change carbohydrate composition).

Carbohydrates
Carbohydrates include monosaccharides (simple sugars), disaccharides and polysaccharides. Glucose is a central metabolic fuel. Polysaccharides such as starch and glycogen store energy, while cellulose provides structural support in plant cell walls. Carbohydrate-modifying enzymes are exploited in industries: amylases break down starch in brewing and baking; cellulases are used in textile processing and biofuel production.

Proteins
Proteins are polymers of amino acids that fold into complex three-dimensional shapes. They serve structural roles (collagen), catalyse reactions (enzymes), mediate transport (hemoglobin), act in immunity (antibodies) and regulate cellular processes (hormones). Protein structure is described by primary (sequence), secondary (alpha-helix, beta-sheet), tertiary (overall folding) and quaternary (assembly of subunits) levels. Biotech produces recombinant proteins such as insulin and enzymes for industrial processes; purification and correct folding are crucial to function.

Lipids
Lipids include fats, oils and membrane phospholipids. They serve as long-term energy stores and form the structural basis of membranes. Membrane lipids affect the fluidity and permeability of cell membranes, influencing processes like transport, signal transduction and membrane protein function. In biotechnology, lipids are important in designing drug delivery systems like liposomes and in studying membrane-associated proteins.

Nucleic acids
DNA and RNA store and transmit genetic information. DNA’s sequence encodes genes; RNA conveys information for protein synthesis and performs regulatory roles. Nucleic acids are central tools in biotechnology: DNA cloning, PCR, sequencing and hybridisation assays all depend on understanding base pairing and nucleic acid chemistry. Manipulating nucleic acids allows control over gene expression and creation of genetically modified organisms.

Interactions and metabolism
These biomolecules do not act in isolation: enzymes (proteins) act on carbohydrate and lipid substrates; nucleic acids encode proteins that regulate metabolic pathways; membrane lipids provide the environment for membrane proteins. Biotechnology often targets pathways connecting these classes, for example engineering microbes to convert carbohydrates into ethanol or modifying enzymes to change product specificity.

Practical considerations
Working with biomolecules requires knowledge of their stability and handling: proteins can denature with heat or pH extremes; RNA is labile and needs careful RNase-free conditions; lipids require organic solvents for extraction. Understanding these properties is essential for laboratory techniques and industrial production.

Molecular building blocks
Both DNA and RNA are nucleic acids built from nucleotide monomers. Each nucleotide consists of a nitrogenous base, a pentose sugar and a phosphate group. In DNA the sugar is deoxyribose and the bases are adenine (A), thymine (T), guanine (G) and cytosine (C). In RNA the sugar is ribose and uracil (U) replaces thymine.

DNA double helix
DNA is typically double-stranded forming a right-handed double helix. The two strands run in opposite directions (antiparallel) and are held together by hydrogen bonds between complementary bases: A pairs with T via two hydrogen bonds and G pairs with C via three hydrogen bonds. The sugar-phosphate backbone runs along the outside of the helix and base pairs are stacked inside, contributing to helix stability through van der Waals interactions and base stacking.

RNA structure and types
RNA is usually single-stranded and more versatile in form. Although single-stranded, RNA can fold back on itself to form secondary structures such as hairpins and loops due to intra-molecular base pairing. Major RNA types include messenger RNA (mRNA) which carries coding information, transfer RNA (tRNA) which brings amino acids to the ribosome, and ribosomal RNA (rRNA) which is a structural and catalytic component of ribosomes. Other regulatory RNAs (miRNA, siRNA) play roles in gene regulation.

Chemical and physical properties
RNA is chemically less stable than DNA because the 2'-OH group on ribose can participate in intramolecular reactions that cleave the backbone; this makes RNA more susceptible to hydrolysis. DNA’s double-stranded form and deoxyribose sugar confer greater stability for long-term information storage. Both molecules can be denatured (strands separated) by heat or chemical agents and renatured (reannealed) when conditions are restored; this property is used in molecular techniques like hybridisation.

Biological consequences of structure
Complementary base pairing underlies replication, transcription and hybridisation technologies. Chargaff’s rules describe base composition in double-stranded DNA where amounts of A ≈ T and G ≈ C. The antiparallel orientation and specific base pairing determine how polymerases read templates and synthesise complementary strands. Understanding these structural features is essential when designing primers for PCR, probes for detection and strategies for cloning.

Applications in biotechnology
Knowledge of nucleic acid structure enables methods such as restriction mapping, PCR primer design, DNA sequencing and RNA interference. For example, designing a primer requires knowing melting temperature which depends on GC content and length, while hybridisation stringency in blotting depends on base-pair stability. These concepts link molecular structure to practical lab work and applications in diagnostics and research.

The flow of genetic information
The central dogma states that genetic information flows from DNA to RNA to protein. This simple statement summarises three fundamental processes: replication (making copies of DNA), transcription (synthesising RNA from DNA) and translation (assembling proteins from mRNA templates). Each step involves specialised enzymes and regulatory factors ensuring fidelity and proper timing.

DNA replication
Replication is the process by which a cell duplicates its genome before cell division. The replication fork is formed as helicase unwinds the double helix. DNA polymerases synthesise new strands by adding nucleotides complementary to the template strand; synthesis proceeds in a 5' to 3' direction. Because the two strands are antiparallel, replication is continuous on the leading strand and discontinuous on the lagging strand, producing short Okazaki fragments that are later joined by DNA ligase. Replication is semi-conservative: each daughter DNA molecule contains one original strand and one newly synthesised strand.

Transcription
Transcription copies a gene’s information into RNA. RNA polymerase recognises promoter sequences and initiates RNA synthesis without needing a primer. In bacteria, transcription often occurs co-transcriptionally with translation. In eukaryotes, primary RNA transcripts undergo processing: a 5' cap is added, introns are removed by splicing, and a 3' poly(A) tail is attached. These processing steps are essential for mRNA stability, transport to the cytoplasm and efficient translation.

Translation
Translation is the process of decoding mRNA to assemble a polypeptide chain. Ribosomes read mRNA codons (triplets of bases), and tRNA molecules with complementary anticodons bring specific amino acids to the ribosome. Translation occurs in three phases: initiation (ribosome assembly at the start codon), elongation (sequential addition of amino acids), and termination (release at a stop codon). The genetic code is nearly universal and redundant, meaning several codons can specify the same amino acid.

Regulation and biotechnology relevance
Gene expression is tightly regulated at transcriptional and post-transcriptional levels. Biotechnology manipulates promoters, enhancers and regulatory sequences to control when and how much of a protein is made. For recombinant protein production, choosing suitable promoters and expression systems ensures correct transcription and translation, while modification of codon usage can improve expression in heterologous hosts. Understanding the central dogma helps students design experiments and troubleshoot expression problems in the lab.

Basic concept
Recombinant DNA technology allows scientists to join DNA fragments from different sources to create new combinations of genetic material. This enables insertion of a gene encoding a desired trait — such as a human protein — into a suitable vector and host, so the host produces the product. The process rests on predictable base-pairing, specific cutting by restriction enzymes and ligation to form stable constructs.

Main steps of recombinant DNA work
Typical steps begin with identification and isolation of the gene of interest. DNA can be cut at chosen sites with restriction enzymes to produce compatible ends. A vector (such as a plasmid) is opened with the same enzymes or compatible ones, and the gene is ligated into the vector using DNA ligase. The recombinant vector is then introduced into a host cell (transformation). Transformed cells are selected using markers and screened to confirm the presence and orientation of the insert.

Choice of vectors and hosts
Vectors must support replication and maintenance in the host and ideally include selectable markers and cloning sites. For cloning only, high-copy plasmids suffice. For expression, vectors include promoters, ribosome binding sites and tags for purification. Hosts are selected based on growth properties, ease of genetic manipulation and ability to process the protein. Bacteria like E. coli are fast and economical; yeast and mammalian cells provide eukaryotic processing when needed.

Considerations for expression and functionality
Successful expression depends on correct reading frame, promoter compatibility and codon usage. A gene may produce a non-functional protein if it lacks required post-translational modifications. In such cases, eukaryotic expression systems are preferred. Moreover, some proteins are toxic to the host; inducible promoters allow controlled expression to reduce harm.

Applications and examples
Recombinant DNA technology is used to produce therapeutic proteins (insulin, growth hormone), develop genetically modified plants, create vaccines and produce research tools like labelled proteins. It also enables gene probes and molecular diagnostics. The power of recombinant DNA comes from combining precise molecular tools with biological systems to produce predictable outcomes.

Safety and ethics
Working with recombinant organisms requires risk assessment and containment appropriate to the organism and product. Ethical considerations include the purpose of modification and potential environmental impacts. Responsible use involves regulation, oversight and transparent communication about benefits and risks.

Restriction enzymes: natural function and laboratory use
Restriction enzymes, or restriction endonucleases, were discovered in bacteria where they defend against invading phage DNA by cutting at specific sequences. In the lab they are indispensable tools because each enzyme recognises a short, often palindromic DNA sequence and cleaves DNA at or near that site. This property allows scientists to cut DNA into reproducible fragments and to join fragments in predictable ways.

Types of cleavage
Depending on their mechanism, restriction enzymes produce 'sticky' (cohesive) ends or 'blunt' ends. Sticky ends result from staggered cuts that leave single-stranded overhangs with specific sequences; when complementary sticky ends meet they can anneal via base pairing, making ligation easier and more specific. Blunt ends are produced by straight cuts across both strands and lack overhangs; ligating blunt ends is less efficient because there is no base pairing to guide the joining.

Practical use and compatibility
Choosing restriction enzymes for cloning requires checking that the enzyme sites are present and unique in the vector and insert, and that the overhangs produced are compatible. Some enzymes produce compatible ends even if their recognition sequences differ, while others have specific buffer and temperature requirements. Double digests using two enzymes can control insert orientation in the vector, important for expression constructs.

DNA ligase: joining the pieces
DNA ligase is the enzyme that seals nicks in the sugar-phosphate backbone by forming phosphodiester bonds, joining adjacent nucleotides. In cloning, after complementary ends are annealed, ligase permanently joins insert and vector DNA. Different ligases (T4 DNA ligase, E. coli DNA ligase) have differing efficiencies and substrate specificities; T4 ligase is commonly used for both sticky and blunt end ligations.

Laboratory workflow and considerations
Typical cloning workflows include digestion of vector and insert with restriction enzymes, purification of fragments by gel electrophoresis, then ligation. Reaction conditions — such as correct buffer, molar ratio of insert to vector and incubation temperature — affect ligation success. For blunt-end ligations or low-efficiency cases, higher concentrations of ligase or special kits may be used.

Applications beyond cloning
Restriction enzymes and ligases are also used in mapping DNA, producing fragments for sequencing, creating recombinant constructs for gene therapy research and assembling synthetic DNA. Their predictable chemistry is central to many molecular biology techniques that students will learn in further study.

What are plasmids and why they matter
Plasmids are naturally occurring extrachromosomal DNA molecules found in bacteria and some eukaryotes. They are usually circular, double-stranded and replicate independently of the host chromosome. Plasmids often carry genes that confer selective advantages, such as antibiotic resistance, which is why they are valuable both in nature and in the laboratory.

Plasmids as cloning vectors
In molecular biology, plasmids are engineered to serve as vectors — vehicles to carry foreign DNA into a host cell. A typical plasmid vector contains an origin of replication to ensure it is maintained in the host; selectable marker genes (for example antibiotic resistance) to select for transformants; and a multiple cloning site (MCS) containing unique restriction sites that allow insertion of DNA fragments. Some plasmids also carry promoters, fusion tags and reporter genes to facilitate expression and detection of cloned genes.

Features that support cloning and expression
For gene expression, vectors include regulatory sequences appropriate for the host: bacterial promoters and ribosome binding sites for prokaryotic expression, or eukaryotic promoters and polyadenylation signals for expression in higher cells. Fusion tags such as His-tags or GST help purify expressed proteins by affinity chromatography. Reporter genes like GFP or lacZ let researchers visually confirm expression or screen for clones.

Types of vectors
Different vectors are designed for specific purposes. Cloning vectors are optimised for insertion and maintenance of DNA. Expression vectors are designed to produce proteins in hosts. Shuttle vectors function in multiple hosts (for example bacteria and yeast), enabling initial cloning in fast-growing bacteria and subsequent expression in a eukaryotic system. Specialized vectors include bacteriophage and viral vectors for high-efficiency delivery or integration into host genomes.

Selecting and using plasmids
Choosing a plasmid depends on the goals: high copy number plasmids yield many copies of the inserted gene for DNA preparation, whereas low copy number plasmids may be preferred when expressing potentially toxic proteins. Selectable markers allow transformed cells to be isolated on antibiotic plates, while screening strategies (blue-white screening, PCR colony screening) help identify clones carrying the desired insert. Maintenance of plasmids requires appropriate growth conditions and selection pressure.

Safety and containment
Using plasmids requires careful handling to prevent unintended release of recombinant DNA into the environment. Laboratories follow biosafety guidelines that match the risk associated with the plasmid and host. Responsible practice includes proper disposal and decontamination of cultures and materials.

Introducing foreign DNA into cells
Transformation refers to the process of introducing foreign DNA into a host cell so that the host acquires new genetic traits. In bacteria, transformation commonly involves taking up plasmid DNA from the environment. In eukaryotic systems, similar processes are called transfection (for non-viral delivery) or transduction (when using viral vectors). The efficiency of DNA uptake and subsequent expression depends on both the method and the biology of the host cell.

Chemical transformation
Chemical methods make cells 'competent' to take up DNA by treating them with divalent cations like calcium chloride. This treatment alters the cell membrane and increases its permeability. After mixing cells with plasmid DNA, a brief heat shock encourages DNA entry. Chemical transformation is simple and inexpensive, widely used in laboratories for E. coli, and works well for many cloning tasks.

Electroporation
Electroporation applies a short high-voltage pulse to cells suspended in an appropriate buffer. This pulse creates temporary pores in the membrane, allowing DNA to enter. Electroporation is more efficient than chemical methods and works for a broader range of organisms, including bacteria, yeast and mammalian cells, but requires specialised equipment and optimized conditions to avoid killing cells.

Other delivery methods
In eukaryotic cells, lipid-based transfection reagents form complexes with DNA that fuse with cell membranes, delivering genetic material. Microinjection physically injects DNA into cells or nuclei and is used in specialized applications like embryo manipulation. Viral vectors harness viruses’ natural ability to enter cells and deliver genetic cargo, making them powerful tools for gene therapy and high-efficiency transduction of mammalian cells.

Choosing host organisms
Hosts are selected based on growth speed, genetic tractability and capacity for correct protein folding and post-translational modifications. E. coli grows rapidly and is simple to manipulate, making it a first choice for many cloning tasks. Yeast (Saccharomyces cerevisiae) is a eukaryote that can perform some post-translational modifications and is used for producing eukaryotic proteins. Mammalian cell lines are needed when human-like glycosylation and complex folding are essential, albeit with higher cost and slower growth.

Selection and screening
After transformation, cells are allowed to recover and then plated onto selective media containing antibiotics; only cells that took up plasmid DNA with a resistance gene survive. Secondary screening (colony PCR, restriction analysis, sequencing) confirms the presence and correctness of the insert. Maintaining selection pressure prevents loss of plasmids during cultivation.

Purpose and significance
PCR (polymerase chain reaction) is a powerful laboratory technique used to amplify a specific segment of DNA into millions of copies in a short time. It is fundamental to molecular biology, diagnostics, forensic analysis and research because it allows detection and manipulation of DNA even from very small samples.

Key components
A PCR reaction requires template DNA containing the target sequence, two primers (short single-stranded DNA oligonucleotides) that flank the target, deoxynucleotide triphosphates (dNTPs), a thermostable DNA polymerase (commonly Taq polymerase), and a buffer with appropriate ions such as Mg2+. Primers define the start and end points of the region to be amplified, and polymerase synthesises new DNA strands from the primers.

Thermal cycling steps
Each PCR cycle has three temperature-controlled steps. Denaturation (around 94–98°C) melts double-stranded DNA into single strands. Annealing (typical temperatures 45–65°C) allows primers to bind to their complementary sequences on the template. Extension (usually 68–72°C for Taq polymerase) is when polymerase extends the primers to synthesise new DNA. Repeating these cycles leads to exponential amplification: ideally 2^n copies after n cycles.

Design and optimisation
Successful PCR depends on careful primer design (appropriate length, GC content and lack of secondary structure), correct annealing temperature, buffer composition and magnesium concentration. High-fidelity polymerases reduce the error rate compared to Taq polymerase, important when amplified DNA will be used for cloning or sequencing. Controls without template (negative controls) check for contamination; positive controls confirm reaction components are functional.

Applications
PCR is used to amplify genes for cloning, to detect pathogen DNA or genetic mutations in diagnostics, in DNA fingerprinting for forensics, and in research to genotype organisms or measure gene expression (via reverse transcription PCR). Variants of PCR, such as quantitative PCR (qPCR) and reverse transcription PCR (RT-PCR), extend the technique to measure gene expression levels and to work from RNA templates.

Limitations and precautions
PCR can amplify contaminant DNA if strict aseptic technique is not followed. Amplification errors can occur if low-fidelity polymerases are used. The size of fragments that can be efficiently amplified depends on the polymerase and conditions. Proper experimental design and controls are essential to obtain reliable results.

Purpose of creating libraries
DNA libraries are collections of DNA fragments cloned into vectors so that researchers can preserve and screen genetic information from an organism or tissue. Libraries allow isolation of specific genes or sequences for study, expression or sequencing without needing to know the exact sequence in advance.

Genomic libraries
Genomic libraries are constructed from an organism’s genomic DNA and, therefore, include both coding and non-coding regions, promoters and regulatory elements. To create a genomic library, genomic DNA is extracted, partially digested or mechanically sheared into fragments of an appropriate size, and these fragments are ligated into vectors such as plasmids, cosmids or bacterial artificial chromosomes (BACs). The ligated vectors are introduced into host cells, and the entire collection of clones together represents the genome. Genomic libraries are useful for studying gene structure, regulatory sequences and genomic organisation.

cDNA libraries
cDNA libraries are made from messenger RNA (mRNA) isolated from a particular tissue or developmental stage. Reverse transcriptase synthesises complementary DNA (cDNA) from mRNA. Because mRNA represents expressed genes at the time of extraction, a cDNA library reflects the transcriptome of that tissue and lacks introns and many regulatory regions. cDNA libraries are especially valuable when the aim is to obtain open reading frames for protein expression or to study gene expression patterns.

Construction steps and considerations
Key steps include DNA or RNA isolation, fragmentation or reverse transcription, ligation into an appropriate vector and transformation into a host strain. For cDNA libraries, mRNA selection (for example poly-A selection) improves representation of protein-coding messages. Size selection helps ensure cloned fragments are of useful length for screening and expression. High-quality starting material and care to avoid RNase contamination are critical for cDNA construction.

Screening and identification
Once a library is constructed, researchers screen clones to find those containing the gene of interest. Screening methods include hybridisation with labelled DNA probes, colony or plaque hybridisation, PCR-based screening and functional complementation assays. Positive clones are further analysed by restriction mapping and sequencing to confirm identity.

Applications
Genomic libraries assist in identifying regulatory regions, intron-exon structures and genomic contexts. cDNA libraries are used to clone genes for protein production, study tissue-specific expression and discover novel transcripts. Both types of libraries historically underpinned large-scale sequencing projects and gene discovery efforts, although modern high-throughput sequencing has changed some practices.

From gene to functional protein
After a gene is cloned into a suitable vector, the next major goal is often to produce the protein encoded by that gene. An expression system comprises the vector, host organism and culture conditions that together enable transcription and translation of the inserted gene into a functional protein. Careful choice of system affects yield, correctness of folding and post-translational modifications.

Bacterial expression systems
E. coli is the most commonly used bacterial host because it grows rapidly, is inexpensive to culture and has well-developed genetic tools. Expression vectors for E. coli include strong promoters (such as T7), ribosome binding sites and often fusion tags for purification. However, E. coli lacks the machinery for many eukaryotic post-translational modifications (glycosylation, complex disulfide bond formation), which can make some eukaryotic proteins inactive when produced in bacteria. Strategies such as expression in the periplasm, co-expression of chaperones, or use of specialised strains can improve folding.

Yeast and fungal systems
Yeast, such as Saccharomyces cerevisiae or Pichia pastoris, are eukaryotic microbes that combine relatively fast growth with the ability to perform some eukaryotic modifications. Yeast systems can secrete proteins into the culture medium, simplifying purification. They are commonly used for producing enzymes, vaccines and biopharmaceuticals where some glycosylation is acceptable or can be engineered.

Insect and mammalian cell culture
Insect cell systems (using baculovirus vectors) and mammalian cell cultures (CHO, HEK293) are used when authentic eukaryotic post-translational modifications are required, for example in therapeutic antibodies. Mammalian cells provide near-human glycosylation patterns and correct processing, but they are more expensive to maintain, grow more slowly and require specialised facilities. Expression in these systems is often used for high-value pharmaceutical proteins where proper folding and activity are essential.

Inducible expression and toxicity control
Some proteins are toxic to host cells; inducible promoters (activated by adding an inducer chemical or changing temperature) allow growth of cultures before turning on expression to reduce harm. Expression temperature, codon optimisation for the host and use of fusion partners can all influence yield and solubility.

Protein purification and analysis
After expression, proteins are recovered by cell lysis (for intracellular proteins) or from the culture medium (for secreted proteins). Purification methods include affinity chromatography (exploiting fusion tags), ion exchange, size exclusion and hydrophobic interaction chromatography. Analytical techniques — SDS-PAGE, Western blotting, activity assays and mass spectrometry — confirm identity, purity and functionality. Proper removal of contaminants and endotoxins is required for therapeutic use and regulated products.

Scale-up and production
Producing proteins at industrial scale requires optimization of fermentation conditions, bioreactor design and downstream processing. Factors such as oxygen supply, pH control, nutrient feed strategy and shear stress affect yield. Regulatory compliance, good manufacturing practice (GMP) and quality control are essential for medical products.

Basics of microbial cultivation
Microbial culture is the controlled growth of microorganisms for study or product formation. Cultures can be maintained on solid media (agar plates) for isolation and colony formation, or in liquid media (broths) for biomass and product production. Media supply necessary nutrients: carbon and energy sources, nitrogen, minerals and vitamins. Sterility and aseptic technique are essential to prevent contamination which can outcompete the intended organism or spoil the product.

Growth phases and their importance
In batch culture, microbial population growth passes through lag phase (cells adapt to new environment and prepare for growth), exponential or log phase (cells divide at maximum rate), stationary phase (growth rate slows due to nutrient depletion or waste accumulation) and death phase (cells die). Many products are optimally produced at specific growth phases; for example, primary metabolites often form during exponential growth, while secondary metabolites may accumulate in stationary phase. Timing harvest based on the growth curve is therefore critical for yield.

Fermentation process control
Fermentation refers to scaling up microbial cultures in bioreactors where conditions such as temperature, pH, dissolved oxygen, agitation and nutrient feed can be precisely controlled. Aerobic organisms require oxygen supply via sparging and agitation; anaerobic processes require exclusion of oxygen. Sensors and control systems monitor parameters to maintain optimal conditions for growth and product formation. Maintaining sterile connections and preventing contamination at scale are practical challenges in industrial settings.

Types of fermentation
Batch fermentation runs without adding fresh medium after inoculation and is simple to operate. Fed-batch fermentation introduces nutrients during the run, allowing higher cell densities and controlled metabolism, which is common in industrial protein production. Continuous fermentation maintains a steady state by continuously adding fresh medium and removing culture; it can be efficient but requires rigorous control to remain stable over long periods.

Downstream processing and quality
After fermentation, product recovery and purification (downstream processing) begin. Steps include cell removal (centrifugation or filtration), extraction of intracellular products, concentration, and chromatography for purification. Downstream processing often determines final product purity and cost. For pharmaceuticals, removal of impurities, endotoxins and validation of identity and activity are critical for regulatory approval.

Applications and examples
Microbial fermentation produces foods (yogurt, cheese), industrial enzymes, antibiotics, amino acids, organic acids and biofuels. Optimising organism strain, medium composition, and process parameters can dramatically improve yields. Fermentation also underpins production of recombinant proteins in host cells when scaled up under controlled conditions.

Overview of medical biotechnology
Biotechnology has transformed healthcare by enabling targeted therapies, safer vaccines and rapid diagnostics. Modern medical biotechnology integrates molecular biology, immunology and cell culture technologies to develop products that prevent, diagnose or treat diseases. These innovations improve patient outcomes and enable public health responses to outbreaks.

Vaccines
Vaccines prepare the immune system to recognise and respond to pathogens without causing full-blown disease. Biotechnology enables subunit and recombinant vaccines where specific antigens are produced in microbial or cell systems, reducing risks compared to whole-pathogen vaccines. Examples include vaccines based on viral proteins expressed in yeast or insect cells. New vaccine platforms, such as mRNA vaccines, use genetic material delivered into host cells to produce antigens in situ, a rapid approach that proved valuable in recent pandemics.

Monoclonal antibodies
Monoclonal antibodies (mAbs) are highly specific proteins produced by identical immune cells cloned from a single parent cell. They can neutralise pathogens, block signalling pathways in cancer, or deliver drugs to target tissues. Production of therapeutic mAbs requires mammalian cell culture to ensure proper folding and glycosylation. Biotechnological advances have produced humanised and fully human antibodies that reduce immune reactions and improve therapeutic safety.

Diagnostics and molecular tests
Diagnostics based on biotechnology detect pathogens, biomarkers or genetic mutations. Enzyme-linked immunosorbent assays (ELISA) detect proteins or antibodies using labelled enzymes, while PCR-based methods amplify pathogen DNA/RNA for sensitive detection. Point-of-care rapid tests provide quick results but may trade off sensitivity. Next-generation sequencing enables pathogen discovery and genomic surveillance. Accurate diagnostics are crucial for patient care and epidemiology.

Personalised medicine
Advances in genomics allow treatments tailored to an individual’s genetic profile. Pharmacogenomics studies how genetic variation affects drug response, guiding dosage and drug choice to improve outcomes and reduce adverse effects. Companion diagnostics pair a therapeutic with a test that identifies patients likely to benefit, bringing precision to treatment selection.

Regulatory and ethical considerations
Medical biotechnology products require rigorous testing for safety and efficacy through clinical trials and regulatory approval. Ethical issues include access to expensive biologics, privacy of genetic data, and equitable distribution of vaccines. Understanding these aspects helps students appreciate scientific challenges alongside societal responsibilities.

Goals for agricultural biotechnology
Agricultural biotechnology aims to improve crop yield, nutritional value, resistance to pests and diseases, and tolerance to environmental stresses such as drought or salinity. The objective is to increase productivity and sustainability while reducing reliance on chemical inputs. Techniques range from genetic modification to tissue culture and molecular marker-assisted breeding.

Genetically modified (GM) crops
GM crops are plants whose genomes have been altered using recombinant DNA techniques to introduce desirable traits. For example, introducing a bacterial Bt gene provides pest resistance by producing a toxin specific to certain insect larvae, reducing the need for chemical pesticides. Herbicide-tolerant crops allow farmers to control weeds more effectively. Other modifications focus on improving nutritional content, such as biofortified crops with higher levels of vitamins or minerals.

Tissue culture and micropropagation
Tissue culture grows plant cells, tissues or organs in sterile, nutrient-controlled media to regenerate whole plants. Micropropagation allows rapid multiplication of elite varieties, production of uniform planting material and generation of disease-free plants by eliminating viruses through meristem culture. Techniques include callus formation, organogenesis and somatic embryogenesis. Tissue culture is widely used for propagation of banana, potato and ornamental plants.

Marker-assisted selection
Marker-assisted selection (MAS) uses DNA markers linked to desirable traits to speed up breeding programs. Instead of waiting for a full plant to grow and express a trait, breeders can test seedlings for molecular markers and select those carrying the desired genes. MAS accelerates breeding for disease resistance, quality traits and abiotic stress tolerance.

Biotic and abiotic stress resistance
Biotechnology develops strategies for resistance to pests (Bt genes, RNAi-based pest control), pathogens (disease-resistant genes) and environmental stresses (genes for drought tolerance). These approaches can stabilise yields under challenging conditions and support food security, but they must be evaluated for ecological impacts like gene flow to wild relatives and effects on non-target organisms.

Socioeconomic and regulatory issues
Adoption of GM crops touches economics, farmer rights, consumer choice and biodiversity. Regulation typically requires risk assessment before environmental release and monitoring after introduction. Public engagement and transparent risk-benefit communication are important to build trust and ensure responsible deployment of biotechnology in agriculture.

Why biosafety matters
Biotechnology works with living organisms and genetic material, so it carries potential risks to people, animals and the environment. Biosafety aims to minimise these risks through measures that prevent accidental exposure, contamination or unintended release. Safe practice protects laboratory workers, the public and ecosystems while allowing beneficial research and applications to proceed.

Biosafety levels and containment
Laboratories are categorised into Biosafety Levels (BSL) 1 to 4 according to the risk posed by the agents handled. BSL-1 is suitable for work with well-characterised, non-pathogenic organisms and requires basic safety practices. BSL-2 handles moderate-risk agents and requires limited containment, personal protective equipment and biohazard signage. BSL-3 works with airborne pathogens and demands specialised engineering controls like directional airflow and restricted access. BSL-4 is for dangerous, often untreatable pathogens and requires fully sealed environments and maximum containment.

Safe laboratory practices
Essential biosafety practices include training personnel, using personal protective equipment (gloves, lab coats, eye protection), practising aseptic technique, decontaminating surfaces and waste, and maintaining proper documentation. Biological materials should be handled in appropriate containment devices such as biological safety cabinets when aerosols may be generated. Waste disposal procedures (autoclaving, chemical disinfection) are required to render organisms non-viable before disposal.

Regulatory frameworks
Governments and international bodies regulate biotechnology through rules on research conduct, environmental release, clinical trials and product approval. Risk assessment evaluates the likelihood and consequences of harm. Approval processes for genetically modified organisms, biopharmaceuticals and diagnostics involve stepwise review, including laboratory data, field trials and monitoring plans. Intellectual property laws and biosafety guidelines influence how biotechnology innovations are developed and shared.

Bioethics and societal concerns
Ethical issues arise in areas such as human gene editing, cloning, access to expensive therapies and ownership of genetic resources. Questions include: who decides acceptable uses of technology, how to protect individual privacy in genetic data, and how to ensure fair access to benefits. Ethical frameworks help balance innovation with respect for persons, justice and non-maleficence.

Responsible conduct and communication
Practitioners must report results honestly, avoid misrepresentation and consider broader impacts. Public communication should be clear about benefits and risks. Education and stakeholder engagement promote informed decision-making. Teaching biosafety, bioethics and regulation gives students the tools to practise biotechnology responsibly and to participate in societal discussions about its applications.